Voyager Therapeutics Stock In The News
| VYGR Stock | USD 5.75 0.09 1.59% |
Our overall analysis of Voyager Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Voyager Therapeutics. The specific impact of Voyager Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Voyager Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Voyager Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Voyager Therapeutics Backtesting and Voyager Therapeutics Hype Analysis. To learn how to invest in Voyager Stock, please use our How to Invest in Voyager Therapeutics guide.
Voyager |
Voyager Therapeutics Today Top News and Investor Outlook
Voyager Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Voyager and other traded companies coverage with news coverage. We help investors stay connected with Voyager headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Voyager Stock performance. Please note that trading solely based on the Voyager Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Voyager Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Voyager earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Voyager Therapeutics that are available to investors today. That information is available publicly through Voyager media outlets and privately through word of mouth or via Voyager internal channels. However, regardless of the origin, that massive amount of Voyager data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Voyager Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Voyager Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Voyager Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Voyager Therapeutics alpha.
Voyager Largest EPS Surprises
Earnings surprises can significantly impact Voyager Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-03 | 2023-06-30 | -0.57 | -0.51 | 0.06 | 10 | ||
2023-03-07 | 2022-12-31 | -0.55 | -0.61 | -0.06 | 10 | ||
2016-11-10 | 2016-09-30 | -0.41 | -0.35 | 0.06 | 14 | ||
2021-05-10 | 2021-03-31 | -0.66 | -0.58 | 0.08 | 12 | ||
2021-08-09 | 2021-06-30 | -0.71 | -0.8 | -0.09 | 12 | ||
2016-05-12 | 2016-03-31 | -0.38 | -0.29 | 0.09 | 23 |
Voyager Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Voyager Therapeutics Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
18th of November 2024
StockNews.com Upgrades Voyager Therapeutics to Buy - MarketBeat at news.google.com
13th of November 2024
Oppenheimer reiterates Voyager stock target, sees positive outlook from TOGETHER study at investing.com
6th of November 2024
Arcus Biosciences, Inc. Reports Q3 Loss, Tops Revenue Estimates at finance.yahoo.com
28th of October 2024
Voyager Therapeutics Expected to Beat Earnings Estimates Can the Stock Move Higher - Yahoo... at news.google.com
17th of October 2024
Improved Revenues Required Before Voyager Therapeutics, Inc. Stocks 27 percent Jump Looks ... at simplywall.st
14th of October 2024
Investing in Voyager Therapeutics three years ago would have delivered you a 58 percent ga... at finance.yahoo.com
11th of October 2024
Disposition of 1266 shares by Todd Carter of Voyager Therapeutics at 7.18 subject to Rule ... at Todd Carter
2nd of October 2024
Disposition of 5999 shares by Fahey Sandell Jacquelyn of Voyager Therapeutics at 5.82 subj... at Fahey Sandell Jacquelyn
1st of October 2024
Acquisition by Jorgensen Nathan D. of 80000 shares of Voyager Therapeutics subject to Rule... at Jorgensen Nathan D.
25th of September 2024
Voyager Therapeutics stock hits 52-week low at 5.95 - Investing.com at news.google.com
5th of September 2024
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TR... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Voyager Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Voyager Therapeutics' short interest history, or implied volatility extrapolated from Voyager Therapeutics options trading.
Additional Tools for Voyager Stock Analysis
When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.